Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 6/20 | 0.33 |
| ▸ | MAOB | P27338 | 6/20 | 0.33 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.33 |
| ▸ | CHRM4 | P08173 | 2/20 | 0.33 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.33 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.33 |
| ▸ | AOC2 | O75106 | 5/20 | 0.30 |
| ▸ | DAO | P14920 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2653890 | 0.81 | HPGD (0.41) | MAOAMAOBCHRM2CHRM4CHRM5 | |
| SCHEMBL449445 | 0.75 | MAOA (0.37) | MAOAMAOBCHRM2CHRM4CHRM5 | |
| SCHEMBL5572317 | 0.72 | MAOA (0.38) | MAOAMAOBCHRM2CHRM4CHRM5 | |
| SCHEMBL2449240 | 0.71 | MAOA (0.37) | MAOAMAOBCHRM2CHRM4CHRM5 | |
| SCHEMBL10654103 | 0.71 | MAOB (0.39) | MAOAMAOBCHRM2CHRM4CHRM5 | |
| SCHEMBL11381215 | 0.71 | MAOA (0.37) | MAOAMAOBCHRM2CHRM4CHRM5 | |
| SCHEMBL1890900 | 0.71 | MAOA (0.37) | MAOAMAOBAOC2DAO | |
| SCHEMBL2452704 | 0.70 | HRH3 (0.37) | MAOAMAOBHPGDTSHRAOC2 | |
| SCHEMBL3568565 | 0.70 | MAOA (0.33) | MAOAMAOBCHRM2CHRM4CHRM5 | |
| SCHEMBL3568561 | 0.70 | HPGD (0.46) | MAOAMAOBHPGDTSHRAOC2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6080860-A | UREA COMPOUND WHERE ONE OF THE UREA NITROGENS IS PART OF AN (UN)SUBSTITUTED 5 OR 6 MEMBERED RING AND/OR THE OTHER UREA NITROGEN IS SUBSTITUTED WITH A 2-CYANO-4,5-DIALKOXYPHENYL GROUP; REACTING WITH ELECTROPHILE TO FORM A LEAVING GROUP | BRANTFORD CHEMICALSS INC. (CA) | 2000-06-27 | — | — | US | claimed |
| US-6080860-A | UREA COMPOUND WHERE ONE OF THE UREA NITROGENS IS PART OF AN (UN)SUBSTITUTED 5 OR 6 MEMBERED RING AND/OR THE OTHER UREA NITROGEN IS SUBSTITUTED WITH A 2-CYANO-4,5-DIALKOXYPHENYL GROUP; REACTING WITH ELECTROPHILE TO FORM A LEAVING GROUP | BRANTFORD CHEMICALSS INC. (CA) | 2000-06-27 | — | — | US | disclosed |
| US-5686612-A | ACCELERATORS IN THE MANUFACTURE OF RUBBER AND ACTIVATORS FOR THIAZOLE ACCELERATORS | BRANTFORD CHEMICALS INC. (CA) | 1997-11-11 | — | — | US | disclosed |
| US-5675006-A | REACTING INTERMEDIATE WITH PIPERAZINE OR 1,4-DIAZAPINE DERIVATIVES OR AMMONIA TO FORM CHEMICAL INTERMEDIATE, CLOSING THE RING | BRANTFORD CHEMICALS INC. (CA) | 1997-10-07 | — | — | US | disclosed |
| EP-0656885-A1 | SYNTHESIS OF 2-SUBSTITUTED QUINAZOLINE COMPOUNDS (SUCH AS TERAZOSIN) AND MEOBENTINE AND BETHANIDINE AND INTERMEDIATES THEREFOR | ACIC (CANADA) INC. (CA) | 1995-06-14 | — | — | EP | disclosed |
| WO-1994005628-A1 | SYNTHESIS OF 2-SUBSTITUTED QUINAZOLINE COMPOUNDS (SUCH AS TERAZOSIN) AND MEOBENTINE AND BETHANIDINE AND INTERMEDIATES THEREFOR | ACIC (CANADA) INC. (CA) | 1994-03-17 | — | — | WO | disclosed |
| US-4472300-A | ANTIMICROBIAL | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1984-09-18 | — | — | US | disclosed |
| US-4207234-A | 4-Unsubstituted azetidinone derivatives and process for preparation thereof | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1980-06-10 | — | — | US | disclosed |